o.canada.com
Humira, Rituxan top list of U.S. costliest drug price increases -report
NEW YORK — AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price hikes accounted for a …